Larissa Staurengo-Ferrari1, Ana C Zarpelon1, Daniela T Longhi-Balbinot1, Mario Marchesi2, Thiago M Cunha3, José C Alves-Filho3, Fernando Q Cunha3, Sergio H Ferreira3, Rubia Casagrande4, Katrina M Miranda2, Waldiceu A Verri5. 1. Departamento de Patologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil. 2. Department of Chemistry and Biochemistry, University of Arizona, Tucson, USA. 3. Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. 4. Department of Pharmaceutical Sciences, University Hospital (Health Science Centre), Londrina State University, Parana, Brazil. 5. Departamento de Patologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil. Electronic address: waverri@uel.br.
Abstract
BACKGROUND: Several lines of evidence have indicated that nitric oxide (NO) plays complex and diverse roles in modulation of pain/analgesia. However, the roles of charged and uncharged congeners of NO are less well understood. In the present study, the antinociceptive effect of the nitroxyl (HNO) donor, Angeli's salt (Na2N2O3; AS) was investigated in models of overt pain-like behavior. Moreover, whether the antinociceptive effect of nitroxyl was dependent on the activation of cGMP (cyclic guanosine monophosphate)/PKG (protein kinase G)/ATP-sensitive potassium channels was addressed. METHODS: The antinociceptive effect of AS was evaluated on phenyl-p-benzoquinone (PBQ)- and acetic acid-induced writhings and via the formalin test. In addition, pharmacological treatments targeting guanylate cyclase (ODQ), PKG (KT5923) and ATP-sensitive potassium channel (glybenclamide) were used. RESULTS: PBQ and acetic acid induced significant writhing responses over 20min. The nociceptive response in these models were significantly reduced in a dose-dependent manner by subcutaneous pre-treatment with AS. Furthermore, AS also inhibited both phases of the formalin test. Subsequently, the inhibitory effect of AS in writhing and flinching responses were prevented by ODQ, KT5823 and glybenclamide, although these inhibitors alone did not alter the writhing score. Furthermore, pretreatment with L-cysteine, an HNO scavenger, confirmed that the antinociceptive effect of AS depends on HNO. CONCLUSION: The present study demonstrates the efficacy of a nitroxyl donor and its analgesic mechanisms in overt pain-like behavior by activating the cGMP/PKG/ATP-sensitive potassium channel (K(+)) signaling pathway.
BACKGROUND: Several lines of evidence have indicated that nitric oxide (NO) plays complex and diverse roles in modulation of pain/analgesia. However, the roles of charged and uncharged congeners of NO are less well understood. In the present study, the antinociceptive effect of the nitroxyl (HNO) donor, Angeli's salt (Na2N2O3; AS) was investigated in models of overt pain-like behavior. Moreover, whether the antinociceptive effect of nitroxyl was dependent on the activation of cGMP (cyclic guanosine monophosphate)/PKG (protein kinase G)/ATP-sensitive potassium channels was addressed. METHODS: The antinociceptive effect of AS was evaluated on phenyl-p-benzoquinone (PBQ)- and acetic acid-induced writhings and via the formalin test. In addition, pharmacological treatments targeting guanylate cyclase (ODQ), PKG (KT5923) and ATP-sensitive potassium channel (glybenclamide) were used. RESULTS:PBQ and acetic acid induced significant writhing responses over 20min. The nociceptive response in these models were significantly reduced in a dose-dependent manner by subcutaneous pre-treatment with AS. Furthermore, AS also inhibited both phases of the formalin test. Subsequently, the inhibitory effect of AS in writhing and flinching responses were prevented by ODQ, KT5823 and glybenclamide, although these inhibitors alone did not alter the writhing score. Furthermore, pretreatment with L-cysteine, an HNO scavenger, confirmed that the antinociceptive effect of AS depends on HNO. CONCLUSION: The present study demonstrates the efficacy of a nitroxyldonor and its analgesic mechanisms in overt pain-like behavior by activating the cGMP/PKG/ATP-sensitive potassium channel (K(+)) signaling pathway.
Authors: Rosa Ventura-Martínez; Myrna Déciga-Campos; Maria Irene Díaz-Reval; Maria Eva González-Trujano; Francisco J López-Muñoz Journal: Eur J Pharmacol Date: 2004-10-25 Impact factor: 4.432
Authors: José C da S Rocha; Magno E B Peixoto; Sônia Jancar; Fernando de Q Cunha; Ronaldo de A Ribeiro; Francisco A C da Rocha Journal: Br J Pharmacol Date: 2002-06 Impact factor: 8.739
Authors: Weiwei An; Lucas S Ryan; Audrey G Reeves; Kevin J Bruemmer; Lyn Mouhaffel; Jeni L Gerberich; Alexander Winters; Ralph P Mason; Alexander R Lippert Journal: Angew Chem Int Ed Engl Date: 2018-12-21 Impact factor: 15.336
Authors: Daniela T Longhi-Balbinot; Ana C Rossaneis; Felipe A Pinho-Ribeiro; Mariana M Bertozzi; Fernando Q Cunha; José C Alves-Filho; Thiago M Cunha; Jean P S Peron; Katrina M Miranda; Rubia Casagrande; Waldiceu A Verri Journal: Chem Biol Interact Date: 2016-06-07 Impact factor: 5.192